119 related articles for article (PubMed ID: 8177029)
1. Effects of vasopressin on haemodynamics in portal hypertensive rats receiving clonidine.
Moreau R; Cailmail S; Lebrec D
Liver; 1994 Feb; 14(1):45-9. PubMed ID: 8177029
[TBL] [Abstract][Full Text] [Related]
2. Lack of vasopressin action on splanchnic hemodynamics during bleeding: a study in conscious, portal hypertensive rats.
Valla D; Girod C; Lee SS; Braillon A; Lebrec D
Hepatology; 1988; 8(1):10-5. PubMed ID: 3257454
[TBL] [Abstract][Full Text] [Related]
3. Haemodynamic responses to a combination of terlipressin and octreotide in portal hypertensive rats.
Moreau R; Cailmail S; Valla D; Lebrec D
Aliment Pharmacol Ther; 1997 Oct; 11(5):993-7. PubMed ID: 9354212
[TBL] [Abstract][Full Text] [Related]
4. Haemodynamic effects of octreotide in portal hypertensive rats receiving propranolol.
Moreau R; Cailmail S; Gadano A; Valla D; Lebrec D
Aliment Pharmacol Ther; 1997 Aug; 11(4):775-9. PubMed ID: 9305488
[TBL] [Abstract][Full Text] [Related]
5. Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension.
Groszmann RJ; Kravetz D; Bosch J; Glickman M; Bruix J; Bredfeldt J; Conn HO; Rodes J; Storer EH
Hepatology; 1982; 2(6):757-62. PubMed ID: 6815044
[TBL] [Abstract][Full Text] [Related]
6. Vasopressin and vasopressin plus nitroglycerin for portal hypertension. Effects on systemic and splanchnic hemodynamics and coronary blood flow.
Rector WG; Hossack KF
J Hepatol; 1989 May; 8(3):308-15. PubMed ID: 2499616
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of a clonidine-induced decrease in portal pressure in normal and cirrhotic conscious rats.
Roulot D; Braillon A; Gaudin C; Ozier Y; Girod C; Lebrec D
Hepatology; 1989 Oct; 10(4):477-81. PubMed ID: 2777209
[TBL] [Abstract][Full Text] [Related]
8. Effects of calcium antagonists on hepatic and systemic hemodynamics in awake portal hypertensive rats.
Nagasawa M; Kawasaki T; Yoshimi T
J Gastroenterol; 1996 Jun; 31(3):366-72. PubMed ID: 8726828
[TBL] [Abstract][Full Text] [Related]
9. Acute haemodynamic effects of losartan in anaesthetized cirrhotic rats.
Heller J; Shiozawa T; Trebicka J; Hennenberg M; Schepke M; Neef M; Sauerbruch T
Eur J Clin Invest; 2003 Nov; 33(11):1006-12. PubMed ID: 14636305
[TBL] [Abstract][Full Text] [Related]
10. Vasopressin and nitroglycerin decrease portal and hepatic venous pressure and hepato-splanchnic blood flow.
Wisén E; Svennerholm K; Bown LS; Houltz E; Rizell M; Lundin S; Ricksten SE
Acta Anaesthesiol Scand; 2018 Aug; 62(7):953-961. PubMed ID: 29578250
[TBL] [Abstract][Full Text] [Related]
11. Vasopressin-induced changes in splanchnic blood flow and hepatic and portal venous pressures in liver resection.
Bown LS; Ricksten SE; Houltz E; Einarsson H; Söndergaard S; Rizell M; Lundin S
Acta Anaesthesiol Scand; 2016 May; 60(5):607-15. PubMed ID: 26763649
[TBL] [Abstract][Full Text] [Related]
12. Alteration in response of the portal tributary vascular bed to the beta-agonist dobutamine in rats with extrahepatic portal hypertension.
Braillon A; Calès P; Girod C; Lebrec D
J Hepatol; 1986; 2(2):267-75. PubMed ID: 3958476
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent effects of a nitric oxide biosynthesis inhibitor on hyperdynamic circulation in two models of portal hypertension in conscious rats.
Pilette C; Kirstetter P; Sogni P; Cailmail S; Moreau R; Lebrec D
J Gastroenterol Hepatol; 1996 Jan; 11(1):1-6. PubMed ID: 8672735
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic effects of vasopressin, alone and in combination with nitroprusside, in patients with liver cirrhosis and portal hypertension.
Mols P; Hallemans R; Van Kuyk M; Melot C; Lejeune P; Ham H; Vertongen F; Naeije R
Ann Surg; 1984 Feb; 199(2):176-81. PubMed ID: 6696534
[TBL] [Abstract][Full Text] [Related]
15. Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranolol.
Lebrec D; Moreau R; Cailmail S; Sogni P; Oberti F; Hadengue A
J Hepatol; 1993 Jan; 17(1):102-7. PubMed ID: 8445208
[TBL] [Abstract][Full Text] [Related]
16. Effects of reserpine administration in two models of portal hypertension in rats.
Lin HC; Yu PC; Lee SD; Tsai YT; Kuo JS; Yang MC
J Hepatol; 1993 Nov; 19(3):413-7. PubMed ID: 8151103
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of nipradilol, a new beta-adrenergic antagonist combined with a nitroxy base, in rats with intra- or extra-hepatic portal hypertension.
Ohsuga M; Cailmail S; Lebrec D
J Hepatol; 1993 Feb; 17(2):236-40. PubMed ID: 8095275
[TBL] [Abstract][Full Text] [Related]
18. The effect of adenosine-induced hypotension on systemic and splanchnic hemodynamics during halothane or sevoflurane anesthesia in the rat.
Crawford MW; Lerman J; Saldivia V; Orrego H; Carmichael FJ
Anesthesiology; 1994 Jan; 80(1):159-67. PubMed ID: 8291705
[TBL] [Abstract][Full Text] [Related]
19. Similarity of arterial and intravenous vasopressin on portal and systemic hemodynamics.
Barr JW; Lakin RC; Rösch J
Gastroenterology; 1975 Jul; 69(1):13-9. PubMed ID: 1150017
[TBL] [Abstract][Full Text] [Related]
20. Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension.
Bernadich C; Bandi JC; Melin P; Bosch J
Hepatology; 1998 Feb; 27(2):351-6. PubMed ID: 9462630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
